still hungry on semaglutide Why Am I Semaglutide? Reasons & What to Do Why Do I Still Feel

Have Cardiovascular Benefits Beyond Weight Loss The SELECT trial showed semaglutide (Wegovy/Ozempic) reduced major cardiovascular events by 20% in patients with established heart disease, independent of how much weight they lost

Aligned with earlier findings, semaglutide treatment at dosages from 0.5 mg to 2 mg weekly demonstrated variable efficacy, from merely preventing further weight gain in Patient 1 to achieving weight loss of up to 14.4% and 11% relative to baseline, in Patient 2 and Patient 3, respectively

If you experience any suspected side effects from medication, report them through the MHRA Yellow Card scheme (www.mhra.gov.uk/yellowcard)

How you care for your skinthrough daily habits and smart ingredient choicescan influence how you age and how your skin responds